Skip Navigation
About
Team
News
Portfolio
Contact
media
In the Media
2023-10-09 // Antimicrobial resistance biotech secures $37M with ex-CureVac CEO Franz-Werner Haas at the helm
Go to Article
2023-10-09 // Gates Foundation spends $40M to boost mRNA vaccine production in Africa and beyond
Go to Article
2022-02-10 // A small Seattle biotech wants to take on GlaxoSmithKline’s emerging Shingrix blockbuster
Go to Article
2022-02-07 // Univercells campus in Jumet ready to produce vaccines
Go to Article
2022-01-27 // Moderna, Excision each enter HIV battle with mRNA and CRISPR tech
Go to Article
2021-12-20 // The Gates Foundation brings new funding to Univercells
Go to Article
Posts pagination
Previous
1
2
3
…
8
Next
Adjuvant seeks out the most innovative life sciences companies in the world.
See our Portfolio